Shock Clinical Trials in Dijon
7 recruitingDijon, France
Showing 1–7 of 7 trials
Recruiting
Not Applicable
Veno-arterial Carbon Dioxide Partial Pressure Difference (CO2gap) for Early Resuscitation of Septic Shock
Septic ShockSepsis - to Reduce Mortality in the Intensive Care Unit
University Hospital, Clermont-Ferrand750 enrolled27 locationsNCT07179276
Recruiting
Phase 1Phase 2
Invobenitug Also Known as Procizumab (PCZ; AK1967) in Critical Cardiovascular Care
Shock, Cardiogenic
4TEEN4 Pharmaceuticals GmbH130 enrolled20 locationsNCT06832722
Recruiting
Phase 3
Efficacy of Early Argipressin in the Management of Intensive Care Patients With Norepinephrine-refractory Vasoplegic Shock
Patients With Norepinephrine-refractory Vasoplegic Shock
Centre Hospitalier Universitaire Dijon390 enrolled1 locationNCT07063680
Recruiting
Evaluation of the Clinical Frailty Scale (CFS) as a Risk Factor of Mortality in Adult Patients ≤65 Years of Age Admitted to Intensive Care for Septic Shock.
FrailtySeptic Shock
Centre Hospitalier de Lens200 enrolled5 locationsNCT05928767
Recruiting
Phase 3
Effect of Early Use of Levosimendan Versus Placebo on Top of a Conventional Strategy of Inotrope Use on a Combined Morbidity-mortality Endpoint in Patients With Cardiogenic Shock
Cardiogenic Shock
Pr Bruno LEVY610 enrolled28 locationsNCT04020263
Recruiting
Phase 3
Effect at 3 Months of Early Empagliflozin Initiation in Cardiogenic Shock Patients on Mortality, Rehospitalization, Left Ventricular Ejection Fraction and Renal Function.
Cardiogenic Shock
Central Hospital, Nancy, France164 enrolled8 locationsNCT05879276
Recruiting
Not Applicable
Fever Control Using External Cooling in Mechanically Ventilated Patients With Septic Shock
Septic Shock
Centre Hospitalier Intercommunal Creteil820 enrolled33 locationsNCT04494074